Bayer CEO Confident of Reaching Adjusted Guidance

The transcript covers a discussion on forecast adjustments due to high inventories in Brazil, currency hedging strategies, and the impact of currency fluctuations. It also addresses the confidence in closing the Monsanto acquisition by year-end, regulatory challenges, and the performance of the healthcare business. The conversation highlights the company's strategic decisions, market conditions, and financial projections.

What adjustments were made to the 2017 forecasts on the crop unit?

How does the current currency situation affect the company's guidance?

What is the company's stance on hedging against currency fluctuations?

What are the anticipated effects of currency fluctuations on the company's financials?

What factors contributed to the weak second quarter performance of the crop business?

What is the company's confidence level regarding the acquisition of Monsanto?

How is the farmer business performing in the United States?